HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-09-15FDA Approved: DESCOVY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for DESCOVY (emtricitabine and tenofovir alafenamide) submitted by Gilead Sciences, Inc., likely…
-
FDA approval · 2021-09-13FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) from Gilead Sci…
-
FDA approval · 2021-09-13FDA Approved: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods' generic fixed-dose tablet containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate through an originalA…
-
FDA approval · 2021-09-10FDA Approved: ODEFSEY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for ODEFSEY, a fixed-dose combination antiretroviral tablet containing emtricitabine, rilpivirin…
-
FDA approval · 2021-09-10FDA Approved: BIKTARVY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for BIKTARVY (bictegravir/emtricitabine/tenofovir alafenamide) from Gilead Sciences, Inc., updating …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-09-09FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) from Gilead S…
-
FDA approval · 2021-09-09FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for TYBOST (cobicistat) from Gilead Sciences, Inc.
-
FDA approval · 2021-08-17FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP.
-
FDA approval · 2021-08-17FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP.
-
FDA approval · 2021-07-29FDA Approved: SYMTUZA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for SYMTUZA (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) from Janssen Products …
-
FDA approval · 2021-07-23FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approves a supplemental application for Prezista (darunavir) submitted by Janssen Products LP.
-
FDA approval · 2021-07-23FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) from Janssen Products LP, updating its labeling to reflect the approved cha…
-
FDA approval · 2021-07-23FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)
FDA approves a supplemental application for PREZCOBIX (DARUNAVIR ETHANOLATE AND COBICISTAT) from Janssen Products, LP.
-
FDA approval · 2021-07-09FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company.
-
FDA approval · 2021-07-09FDA Approved: TIVICAY PD — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Tivicay PD (dolutegravir sodium) submitted by ViiV Healthcare Company.
-
FDA approval · 2021-07-01FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the Original Application for a generic fixed-dose combination emtricitabine and tenofovir disoproxil fumarate from Zydus Pharma…
-
FDA approval · 2021-06-28FDA Approved: SYMTUZA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for SYMTUZA (darunavir/cobicistat/emtricitabine/tenofovir alafenamide) submitted by Janssen Prod…
-
FDA approval · 2021-06-14FDA Approved: ETRAVIRINE — Original Application (AvKARE)
The FDA approved AvKARE's original application for etravirine, a NNRTI used in combination with other antiretrovirals to treat HIV-1 infecti…
-
FDA approval · 2021-06-04FDA Approved: LOPINAVIR AND RITONAVIR — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for a generic lopinavir/ritonavir product for the treatment of HIV-1 infection…
-
FDA approval · 2021-06-04FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' generic fixed-dose combination emtricitabine and tenofovir disoproxil fumarate (emtricitabine/tenofovir …
-
FDA approval · 2021-05-18FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Isentress (raltegravir) from Merck, indicating an approval under NDA205786.
-
FDA approval · 2021-04-30FDA Approved: ATAZANAVIR — Original Application (Laurus Labs Limited)
The FDA approved Laurus Labs Limited's generic atazanavir through an original ANDA (ANDA 212579).
-
FDA approval · 2021-04-02FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s generic emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) under an Original Application (ANDA), ma…
-
FDA approval · 2021-03-24FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for Viracept (nelfinavir mesylate) from Agouron. The approval acknowledges a change to the product v…
-
FDA approval · 2021-03-24FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for VIRACEPT (nelfinavir mesylate) from Agouron.